Motohiro Imano

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial

Hironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima et al. · Journal of Clinical Oncology · 2018 · 347 citations

Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma

Masashi Yanae, Masanobu Tsubaki, Takao Satou et al. · Journal of Experimental & Clinical Cancer Research · 2011 · 123 citations · Full text

Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines

Masanobu Tsubaki, Makiko Komai, Shinichiro Fujimoto et al. · Journal of Experimental & Clinical Cancer Research · 2013 · 107 citations · Full text

Expression of manganese superoxide dismutase in esophageal and gastric cancers

Ryo Izutani, Satoshi Asano, Motohiro Imano et al. · Journal of Gastroenterology · 1998 · 101 citations

Esophageal Cancer, Biochemistry, Lipid Peroxidation +8

Phase II study of intraperitoneal paclitaxel plus S-1/oxaliplatin for gastric cancer with peritoneal metastasis: SOX+IP PTX trial.

Yoshiyuki Fujiwara, Hironori Ishigami, Hiroto Miwa et al. · Journal of Clinical Oncology · 2016 · 97 citations

Surgical Oncology, Oncology, Sox+ip Ptx Trial +15